You searched for theradaptive

Theradaptive Obtains FDA IDE Approval to Study OsteoAdapt SP in Additional Spinal Fusion Indications

Theradaptive to Study OsteoAdapt SP in Additional Fusion Indications

FDA approved an expansion to its Phase I/II clinical program to include three spinal fusion indications and tripling the number of investigational sites in the U.S.

Dec 10, 2024

Treatment Opens in Spinal Fusion Trial with Theradaptive OsteoAdapt SP

Orthobiologics

The first patient has been treated in the Phase I/II OASIS Trial, a study evaluating the safety and effectiveness of OsteoAdapt SP in spinal fusion procedures.

Sep 11, 2024

11 Orthopedic Startups Announce New Funding in 2Q24

Investments

Startups representing all orthopedic market segments secured new funding to conduct clinical trials and advance commercialization efforts.

Jun 27, 2024

Theradaptive Secures Funding to Support Human Clinical Trials

Investments

Funds from the Maryland Stem Cell Research Fund will support human clinical trials for OsteoAdapt SP in transforaminal lumbar interbody spinal fusion.

May 28, 2024

Phase I/II Clinical Trials for Theradaptive OsteoAdapt SP

Orthobiologics

Theradaptive gained FDA approval for their IDE submission to enroll patients into OASIS, a global Phase I/II Feasibility study in spine fusion.

Feb 01, 2024

Theradaptive Awarded DOD Clinical Trial Award

Investments

This award will help Theradaptive scale up the production of its OsteoAdapt regenerative therapeutic product for spine and trauma repair.

Sep 26, 2023

Theradaptive Closes $26 Million Investment Round

Investments

The company's proprietary protein-engineering platform produces targeted therapeutics that can coat implants and devices to achieve hyper-local delivery over long time periods.

Jun 15, 2023